STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ICAD ICAD INCORPORATED StockScouter® Report
5
StockScouter® Score
ICAD INCORPORATED, a micro cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
- Short-term relative price momentum exhibits moderate strength. Postive/Neutral
Concerns
- Moving average analysis for ICAD suggests downward price movement over the medium term. Negative
- Shares are being sold by financial institutions. Slightly negative for a small company like ICAD
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
A
C
C
C